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INTRODUCTION 
AIDS has become a great and powerful symbol for a world threatened 
by its divisions. In a deep and remarkable way, the child with AIDS is the 
world’s child, the man or woman dying of AIDS has become the world’s image 
of our own mortality. 
Jonathan Mann 
Director Global programme on AIDS, WHO 
Infection with Human Immunodeficiency Virus (HIV) and its end stage, 
Acquired Immunodeficiency Syndrome (AIDS) is the major public health 
challenge of our times, with over 25 million persons already dead and over 50 
million living with HIV/AIDS, the majority of whom, without access to 
therapy. 
AIDS was first recognized in the US in 1981 with reports of 
unexplained opportunistic infections, including Pneumocystis jirovecii 
(formerly Pneumocystis carinii), pneumonia and Kaposi’s Sarcoma (KS) 
among homosexual men in New York and San Francisco (Cleghorn, Reitzfr, 
and Gallo; 2000). 
The first case of HIV infection in India was diagnosed among 
commercial sex workers in Chennai, Tamil Nadu, 1986. 
 HIV / AIDS is a major public health problem all over the world. The 
overwhelming majority of HIV infected people, more than 90%, live in the 
developing world and most of them do not even know that they are infected. 
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This epidemic killed about 3 million people all over the world in the year 2004. 
Globally more than 40 million people are infected with HIV (Training Module 
on continuum of care for health care provider 2005 TNAIDS control society). 
 According to the HIV sentinel surveillance report 2005, an estimated 
5.206 million people in India were infected with HIV. Out of the total HIV 
infection 38.4% were females; 57% lived in the rural areas. (HIV & AIDS 
epidemiological surveillance & estimation report for the year 2005) 
 Psychiatric disorders, including mood disorders, anxiety disorders, 
substance use disorders, cognitive disorders, personality disorders, psychotic 
disorders and delirium are highly prevalent among patients infected with HIV.  
Psychopathology may have impact on treatment adherence, quality of life, 
social and adaptive functioning and possibly HIV – illness progression 
(Robinson and Quaqish 2002). During the course of illness, upto 85% of HIV – 
seropositive individuals report some depressive symptoms and upto 50% 
experience major depressive disorder. In a metaanalysis of published studies, 
Ciesla and Robert (2001) found that people with HIV were almost twice as 
likely as those who are HIV – Seronegative to be diagnosed with major 
depressive disorder and that depression was equally prevalent in people with 
both symptomatic and asymptomatic HIV. Life time prevalence rates of 
anxiety disorders are higher in the HIV clinical population as a whole than in 
the general population (Blalock et al 2005). Initial symptoms of HIV infection 
are neuropsychological in 10% to 30% of cases (Lezak – 1995).  
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LEPROSY 
 The first description of Leprosy came from India about 600 BC. The 
disease was called Kushta and was described as being different from vitiligo. 
 The origin of leprosy is, however, still a mystery, and some recent 
evaluations pointed out that Mycobacterium leprae, the etiological 
microorganism, is a degenerative mycobacterium that came in contact with 
humans when the first farmer settled in the Middle East, Europe and Asia 
thousands of years ago (Young, D.Robertson, et al, 2001). 
 Leprosy is also known as Hansen’s disease, after demonstration of 
Mycobacterium leprae by Gerhard Amauer Hansen in 
1873(Hansen,Galooft,1895).  
The lesions of leprosy predominantly affect the skin, nasal mucosa and 
peripheral and superficial nerves. This is because Mycobacterium leprae grows 
best in cooler tissues.  
Estimates of the total number of cases of leprosy worldwide vary from 8 
million – 10 million.  Most of the cases are in South East Asia, especially in 
India (10 cases per 1000 inhabitants) and in sub- Saharan Africa, where the 
disease reaches high endemic level (>40 cases per 1000 inhabitants). Leprosy 
affects males more frequently than females in a ratio of 2:1. Socioeconomic 
factors play an important role in leprosy around the world and account for the 
failure of imported cases to produce Secondary cases in Europe and United 
States. 
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Although Leprosy is a chronic infectious disease, it may be considered 
an immunological disease to a great extent, partially explaining the differing 
clinical pattern. Two different classifications are used - the Madrid 
classification (International congress of leprosy, 1966), accurate for clinical 
evaluation of leprosy patients, and the Ridley – Jopling classification useful for 
immunological classification.  According to the Madrid classification, leprosy 
can be subdivided into 4 different types; Lepromatous, Tuberculoid, Borderline 
and Indeterminate forms. 
 For the treatment of a large population, patients may be divided into 
Paucibacillary cases (Tuberculoid and Indeterminate leprosy) and 
Multibacillary (Lepromatous and Borderline leprosy). 
The clinical manifestations of leprosy vary from hypopigmented 
macules to widespread damage to peripheral nerves, skin, eyes and bones 
leading to deformity and disability.  
 Leprosy is still a major public health problem in India, even though the 
prevalence rates have come down from 57.6 cases per 10,000 population 
(1981) to 2.7 cases per 10,000 population (September 2003) (Dhilion et al ). 
Reduction in prevalence rate alone, however, is not sufficient because, the 
social consequence of the disease on the life of patients is often severe and 
persists even after its cure (Santosh K. Chaturvede et al). 
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REVIEW OF LITERATURE 
INTRODUCTION 
 Acquired Immunodeficiency Syndrome was demonstrated to result from 
infection with a virus belonging to the family of Retroviruses. It is highly 
neurotrophic and lymphotrophic.  
MODE OF TRANSMISSION 
 HIV is present in blood, semen, cervical and vaginal secretions and to a 
lesser extent in saliva, tears, breast milk and the cerebrospinal fluid of those 
who are infected (Sadock and Sadock, 2003). The modes of transmission 
include heterosexual and homosexual contact, vertical transmission, and 
instrumental transmission, which involves introduction of HIV – contaminated 
fluids or materials into the body by means of needles, blood products or various 
medical accidents. Receptive fellatio involving ejaculation of HIV – infected 
semen is another potential mode, but the actual risk is not known. Kissing is 
not considered a risk unless there is extensive oral disease with open sores. 
Worldwide, the sexual mode of transmission is the most important (Sadock & 
Sadock, 2000). 
 The chance of becoming infected after a single exposure is relatively 
low : 0.8 to 3.2% in unprotected receptive anal intercourse, 0.05 to 0.15% with 
unprotected vaginal sex, 0.32% after puncture with an HIV – contaminated 
needle and 0.67% after using a contaminated needle to inject drugs.  
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PSYCHIATRIC ASPECTS OF HIV INFECTION AND AIDS 
Neuropsychiatric phenomena occurring during the course of HIV 
infection and AIDS can broadly be considered under neurobiological, 
psychobiological and psychosocial aspects. These phenomena can be the result 
of direct infection of the central nervous system with HIV, opportunistic 
infections that occur in the central nervous system, individual psychological 
reactions to HIV disease and its consequences, the social implications of the 
disease and side effects of medications taken to manage the disease. Thus, the 
broad range of mental health problems associated with HIV infection includes 
not only understandable emotional reactions to the illness, but also frank 
psychiatric disorders and neuropsychiatric syndromes. 
Research has been carried out on the psychological status of people with 
HIV infection, including those at different stages of the illness, such as at the 
time of HIV testing, during asymptomatic and symptomatic stages of the 
illness. Notification of a positive test result is usually associated with severe, if 
transient, distress. Common diagnosis given to asymptomatic individuals 
referred to mental health services are adjustment disorder, major 
depression and other forms of depression, substance misuse, panic disorder and 
personality problems. A large number of symptomatic HIV patients present 
with depression (Perry and Tross, 1984; Dilley et al, 1985), while other 
common diagnosis in this group includes organic brain syndromes.  
A number of studies have assessed the prevalence of psychiatric 
disorders in HIV positive patients (Seth 1991; Faulstich 1987; Maj 1994). King 
et al (1989) reported that 31% of a sample of 192 outpatients with HIV 
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infection and AIDS had significant psychiatric problems. In a study done by 
Lykestos et al (1994) on HIV positive patients attending a medical outpatient 
clinic, 54% had a psychiatric disorder, with an additional 22% diagnosed with 
substance use disorder. Lluch et al, on evaluating psychopathology in an 
inpatient sample of 25 AIDS patients, found that 80% had a psychiatric 
diagnosis, of which, the greatest number showed depressive symptoms. A 
study done in Spain by Ayuso et al (1996) on AIDS patients detected 
psychoactive substance use to be the principal diagnosis followed by 
adjustment disorder. As most available studies had been done on western 
populations, the WHO in 1994 implemented a cross-cultural venture called the 
WHO Neuropsychiatric AIDS study. The overall prevalence of current mental 
disorder was significantly higher in seropositive compared to seronegative 
patients in two of the five centers in the study. Probably one of the first 
reported studies on psychiatric morbidity in HIV infected individuals in India, 
by Jacob et al, documented an overall psychiatric morbidity of 26.1 %. 
Some other studies done by Atkinson et al (1988) and Williams et al 
(1991) did not find a significant difference between HIV positive and negative 
controls with respect to prevalence of psychiatric morbidity. 
Factors associated with the development of psychiatric disorders in HIV 
positive individuals have been studied: 
 HIV related factors - mental health symptoms are more likely to occur at 
two stages; i.e., when the person is given a diagnosis of HIV infection 
and when physical symptoms develop or worsen (Davis et al 1995; Holt 
et al 1998). 
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 Personality factors - there is some evidence to show that people with 
personality disorders, in particular those with borderline or antisocial 
personality disorder are at a greater risk of acquiring HIV infection 
(Johnson et al 1996; Golding & Perkins 1996). It is suggested that 
people with personality disorders have less effective coping styles. 
 Past psychiatric history (Dew et al, 1990; Catalan et al, 1992). 
 Social support - individuals lacking in adequate social support usually 
report greater levels of psychological distress (Catalan et al, 1995; Katz 
et al1996) 
 Adverse life events - multiple bereavements, loss of supports, survivor's 
guilt and concerns about one's own health can conspire to make what is 
already a difficult situation, extremely hard to cope with, leading to 
unresolved and complex grief reactions (Sherr et al, 1995; Fishman and 
Perry, 1989). 
 Sociodemographic characteristics - Older individuals may be at a greater 
risk for cognitive impairment and dementia (Catalan et al, 1995). 
Injecting drug users have the poorest psychological status, often having 
experienced social and psychological difficulties prior to acquiring the 
infection (Gala et al, 1993). 
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PSYCHIATRIC DISORDERS AND HIV 
A)  ACUTE STRESS REACTIONS 
Psychological reactions to the diagnosis of HIV infection resemble those 
commonly described in response to the diagnosis of cancer or other life 
threatening diseases. However, in view of the specific psychosocial dimensions 
relevant to HIV, subjects receiving the diagnosis are suddenly confronted not 
only with the likelihood of developing a disease with a very poor prognosis, but 
also with various other issues: revealing their homosexuality / drug abuse to 
family, friends and colleagues; dealing with the fear of partners, friends and 
public; avoiding transmitting the infection to others and protecting themselves 
from opportunistic infection (Christ et al, 1988; Miller 1988). For all the above 
reasons, it is not surprising that acute stress reactions have been reported in 
upto 90% of subjects with a recent diagnosis of HIV (WHO, 1988). 
Acute stress reaction may occur in any phase of the infection, with 
various changes in the person's clinical state. However, it is most common 
immediately after the diagnosis. It has also been found to occur most frequently 
in subjects lacking a partner or living in a rural environment according to 
reports from Germany (Seidl & Goebel, 1987), and also to be more common in 
homosexuals. Apart from clinical features of confusion, bewilderment, 
derealization and sleep disturbances are noted initially following the diagnosis; 
other emotional and behavioural reactions may include anger, withdrawal, 
guilt, denial, fear, despair (Morin et al, 1984; Dilley et al 1985, Miller 1995). 
Management focuses primarily on preventive measures such as pretest and post 
test counseling. 
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B)  ADJUSTMENT DISORDERS 
This is characterized by a morbid (that is excessive in length and/or 
intensity) response to the diagnosis of HIV infection or AIDS, or more 
generally to the stress associated with the disease. The clinical features may be 
characterized by depression, anxiety or obsessions and compulsions, and the 
disorder may last many months (WHO, 1988). Adjustment disorder has been 
reported to be the most frequent diagnosis in patient's with ARC or AIDS 
referred for psychiatric consultation (Dilley et al, 1985; Tross et al, 1986; 
Rundell et al, 1988; Schaerf et al 1989). 
The disorder can be conditioned by several factors: subject's coping 
strategies (Namir et al, 1(87), subjects who have internalized social non 
acceptance of drug abuse or homosexuality leading to feelings of guilt and self 
depreciation (Hays & Lyles, 1986; Miller, 1988), previous history of 
psychiatric disorders (Holland & Tross, 1985), family estrangement (Miller 
1988), over concern over the impact of the illness on loved ones, financial 
difficulties, and poor social support (Zich and Temoshok 1987). 
Management involves behavioural and cognitive psychotherapy on an 
individual or group basis, involving partners or family members as patients 
judge appropriate (Miller, 1988). Pharmacological treatment of depressive or 
anxiety symptoms may be required. 
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C)  MOOD DISORDERS 
i)  DEPRESSIVE SYNDROMES: 
A depressive syndrome not fulfilling the ICD-10 or DSM- IV criteria for 
depressive episode may occur at any point in the course of HIV infection 
(WHO, 1988). Major depressive disorder has been reported in subjects with 
HIV infection but estimates concerning its prevalence have been quite 
divergent. In a study of admitted AIDS patients done by Perry and Tross 
(1984), 82.7% showed mood disturbance with 17.3% fulfilling criteria for 
major depressive disorder. In hospitalized patients, this rate may be higher and 
approach 40%.  Rundell et al (1988) after reviewing records of 111 HIV 
positive subjects seen at a Medical Air Force Centre in Texas, found major 
depressive disorder in 3.6% of the sample. Schaerf et al (1989) found a 
prevalence of 7% in a sample of AIDS patients, which was comparatively less 
than the prevalence of depressive disorders in a sample of general hospital 
consultations. Similar low rates of current major depression in men with AIDS 
was reported by Rabkin et al 1997, who found overall rates of 5-10% with no 
significant difference between HIV negative men, HIV positive men without 
AIDS and men with AIDS defining conditions.  
Inspite of these studies, others have reported rates of current major 
depression in HIV populations elevated two folds above those in healthy 
community samples and usually in the range found with other chronic medical 
illnesses (Atkinson et al 1988, Perry) 1990, William et al, 1991. In view of 
these vastly differing results Jeffrey Ciesla (2001) conducted a meta-analysis of 
10 studies conducted from 1988 to 1998, which compared the rates of current 
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major depression between HIV positive and HIV negative groups. Though 
most of these studies concluded that the infection was not associated with a 
higher rate of the disorder, the results of the  meta-analysis showed that the 
frequency of major depressive disorder was nearly 2 times higher in HIV 
positive than HIV negative persons with no relation to sexual orientation or 
disease stage.  
The relationship between depression and disease progression in HIV has 
also been studied. A 10 year multicentre AIDS Cohort study by Lykestos et al 
(1996), showed a dramatic sustained rise in depressive symptoms as AIDS 
develops, with prior depression, HIV disease related factors and psychiatric 
stressors contributing to this risk.  
Major depressive disorder in HIV may be interpreted in several ways:  
 It may result from psychosocial problems related to the illness. 
 May be directly related to HIV infection of the brain, in particular the 
predilection of the Virus for limbic areas, believed to control emotional 
experience. 
 Predisposing factors in a vulnerable subject. 
 From chance association. 
 May result from secondary effects of the infection i.e., opportunistic 
infections or neoplasms (Perry & Tross, 1984), or use of antineoplastic 
drugs (Volberding et al 1985). 
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It is important to emphasize that depressive symptoms may be difficult 
to differentiate from some manifestations of AIDS Related Complex (fatigue, 
anorexia, weight loss, decreased libido) or of dementia (decreased memory and 
concentration). 
ii)  MANIC SYNDROMES 
A few cases of hypomania or mania in subjects with HIV infection have 
also been described. The possible interpretations are similar to those proposed 
for acute psychotic disorder, with mania occurring either in the context of 
cognitive impairment (Gabel et al 1986: Schmidt & Miller, 1988), or in the 
absence of cognitive impairment (Schmidt & Miller 1988; Buhrich et al, 1988). 
D)  ANXIETY DISORDERS 
Symptoms of anxiety determined by self report checklist tend to be 
higher in medically asymptomatic HIV positive patients than HIV negative at-
risk samples (Atkinson et al, 1989). But other studies have reported that anxiety 
disorders may be common in groups at high risk for HIV infection, irrespective 
of HIV status (Baer 1989; Perry 1990). Six month prevalence rates of 
generalized anxiety disorder in HIV positive men are in the ranges of 15-20 
percent (Atkinson & Grant 1994). Rates of other anxiety disorders do not 
appear to be markedly elevated (William, 1991; Perry 1990). Simple phobias 
and hypoactive sexual desire disorder have been reported (Rundell & Brown 
1990). 
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E)  ACUTE PSYCHOTIC DISORDERS 
 With evidence of cognitive impairment 
Hallucinations (either visual or auditory) and delusions (either 
persecutory or grandiose) are not infrequent in patients with ARC or AIDS. 
They may occur in the context of cognitive impairment which may sometimes 
be subtle or fluctuating (Nurnberg et al, 1984; Rundell, 1990; Thomas & 
Szabadi, 1987) or they may be initially the only psychopathological 
manifestation. 
 Without evidence of cognitive impairment 
Patients with asymptomatic HIV infection, AIDS Related Complex or 
AIDS, who developed acute psychotic disorders without any evidence of 
cognitive impairment throughout the episode, have been reported (Thomas et 
al, 1985; Halevie-Goldman et al, ] 987: Buhrich et al 1988). The interpretation 
for this has already been outlined under manic disorders. A specific 
vulnerability of dopaminergic systems in AIDS has been suggested by Holland 
et al (1985). The predilection of HIV for the limbic system has also been 
discussed in connection with a case of catatonia in a HIV positive subject in 
whom PET scan showed increased blood flow in the right temporal cortex and 
basal ganglia (Volkow et al, 1987). 
Though there have been numerous case reports of psychosis in HIV 
infection and AIDS with estimated rates of 0.1 to 5% (Sewell et al, 1994; 
Harris et al 1991; Buhrich 1988), accurate estimates of incidence and 
prevalence as compared to the general population is completely unknown (Maj 
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1990). Treatment interventions studied in this group have found the response to 
neuroleptics to be favourable, but AIDS patients are highly susceptible to the 
extrapyramidal side effects of antipsychotic drugs. 
F)  HIV DEMENTIA 
The HIV virus being highly neurotrophic, neuropsychological 
abnormalities are commonly present in HIV infected individuals. Clinically 
apparent central nervous system disease occurs in at least 20-40% of AIDS 
patients (Wolcott et al 1989). 
HIV dementia is currently believed to be caused by the infection of the 
brain with HIV (Navia et al, 1986). The onset is usually insidious. Early 
symptoms can be subdivided into three groups: cognitive, behavioural and 
motor (Navia et al, 1986; Price et al 1988). Behavioural symptoms include 
apathy, reduced spontaneity and social withdrawal. Depression, irritability, 
emotional lability, agitation and psychotic symptoms can rarely occur. 
Estimates of the prevalence of HIV dementia varies according to the sample 
studied, the stage of illness and the criteria used for diagnosis. Janssen et al 
(1989) reported that of the adults in his study, 6.5% had HIV dementia, and 
3.0% were reported to have it as the only early manifestation of AIDS. 
Previous estimates of the point prevalence of HIV dementia in AIDS patients 
ranged from 8-16% (WHO 1988).  
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As expected, the prevalence is found to be much higher in autopsy series 
of cases reported to neurologists, reaching the figure of 66% (Price et al, 1988). 
Neurological abnormalities have been reported in a substantial proportion of 
symptomatic HIV positive subjects, not showing the clinical picture of HIV 
dementia. Neurocognitive impairment in the asymptomatic phase of HIV 
infection remains controversial (Grant et al 1989). 
G)  DELIRIUM 
Delirium has been described both in relation to HIV dementia (Price et 
al, 1988) and to the aseptic meningitis which may occur following infection. Its 
occurrence in AIDS patients may be related to hypoxia (from Pneumocystis 
carinii pneumonia) Cryptococcus meningitis, systemic infections, space 
occupying lesions of the brain (CNS lymphoma or brain abscesses due to 
toxoplasmosis), metabolic impairments and the use of psychotropic 
medications (especially tricyclic antidepressants, whose central anticholinergic 
activity seems to be more pronounced in such patients). 
The syndrome usually develops over a short period of time (hours to 
days) with fluctuations in intensity over the course of a day. Complete recovery 
of delirium usually occurs at the time of seroconversion, but delirium 
superimposed on HIV dementia may aggravate its course (Price et al 1988). 
Available estimates of the prevalence and incidence of HIV delirium in 
HIV infection are lacking. 
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H)  SUBSTANCE USE DISORDERS 
Groups at highest risk for HIV infection also commonly have substance 
use disorders and alcohol dependence (Atkinson et al, 1988; Baer 1989). 
Though many alcoholics have a chronic history of substance use, alcohol use 
disorders may occur in some individuals due to the stress of the disease and 
physical disability. 
I)  PERSONALITY DISORDERS 
Perkins et al (1993) assessed personality disorders in a HIV positive 
population and found the prevalence to be fairly high. Patients with personality 
disorders may experience greater dysphoria and are more likely to cope with 
the threat of AIDS in a dysfunctional way. 
J)  OTHER AIDS RELATED PSYCHOPATHOLOGY 
 Delusions - It is well known that psychotic patients tend to incorporate 
in their delusions, topics that are of public interest. Several authors have 
described delusions of having contracted AIDS in patients suffering 
from psychotic depression, schizoaffective disorder or paranoid 
schizophrenia (Rapaport & Braff, 1988; O'Brien, 1987; Shetty, 1988) 
with the most frequent occurrence in psychotic depression. 
 Suicidal attempts by contracting AIDS (Francis et al Ins: Flavin et al 
1986) – Highest risk in homosexual men who are depressed or alcoholic. 
 Factitious AIDS (Miller et ~ 1986) 
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K)  AIDS RELATED PSYCHOPATHOLOGY IN SUBJECTS      
 WITHOUT HIV INFECTION 
Hypochondriacal syndrome (the 'worried well') a syndrome marked by 
the persistent belief in the presence of HIV infection despite repeated negative 
serological tests and clinical examinations has been described by various 
authors (Forstein, 1984; Miller, 1988). 
PSYCHIATRIC DISORDERS AND LEPROSY 
The skin is the most visible organ and plays a significant role in 
determining one’s self – image. An individual with chronic visible 
dermatological lesions may have psychological distress. It is estimated that 
psychological problems in those attending the dermatological outpatient is as 
high as 40% to 80% (Medansky and Handler). 
Among the dermatological conditions, leprosy occupies a unique place 
in that it is not only disfiguring but also disabling and is associated with a high 
level of stigma.  
The available literature indicates that the prevalence of emotional 
disturbances in those suffering from leprosy is high (Campos et al 1980). 
Studies done in India have also confirmed the high prevalence of 
psychiatric morbidity in persons affected by Leprosy. Epidemiological study 
done by Kumar and Verghese (1980) found the prevalence of psychiatric 
morbidity in leprosy population in the community to be 99 per 1000 in 
comparison to 63 per 1000 in the general population. 
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A study done by Bharath et al found a prevalence of psychiatric 
morbidity in a clinical population of patients with leprosy in South India to be 
12.2%, less than that in the control group of psoriatic patients. 
Three factors were found to correlate with psychiatric morbidity in a 
population of leprosy patients. 
 
 
 
 
 
 
Studies done by Kumar and Verghese, 1980, Ramanathan et al 1984, 
Verma and Shivaguntam, 1984, found that physical deformity has been 
identified as an important correlate. 
 Bharath et al found that there is significant correlation between 
psychiatric morbidity and knowledge about the disease, social, emotional and 
health adjustment (P<0.01). There was no correlation between psychiatric 
morbidity and duration of illness, perceived negative attitude of the family 
members, occupation and home adjustment. 
Psychiatric 
morbidity 
Lack of appropriate 
knowledge 
Social stigma Disability  
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When the condition is first diagnosed, the patient goes through 
sequences of reaction well described by Kuble – Ross and others – denial, 
anger, bargaining, depression and acceptance. [Henry R. Oliver 1987.] 
ADJUSTMENT DISORDER  
 It is a common reaction in the initial stage. Some studies found that 
more than 50% of leprosy patients had adjustment problem initially. A study 
done by Mitchell G. Weiss et al using the explanatory model interview 
catalogue found a prevalence of adjustment disorder of 26.8% in leprosy 
patients. 
DEPRESSION  
 The commonest psychiatric diagnosis is depression. Depression was 
positively correlated with physical disability and marital status, but not with 
age, sex, education, type of leprosy or duration of illness (Kisivuli et al ). 
 Mitchell G. Weiss et al found a prevalence of major depression of 
17.9% in an outpatient sample. Henry R Oliver found 46% prevalence of major 
depressive disorder in a hospital based sample. Statistically significant 
difference was found between non rehabilitated group (66.6%) and 
rehabilitated group (41.3%) in a study done by K.K Verma et al. 
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STIGMA 
 Stigma is a society’s negative evaluation of particular features of 
behaviour. There is a great deal of variability in approaches to define stigma. 
Goffmann defined stigma as an “attribute that is deeply discrediting” that 
reduces the bearer “from a whole and usual person to a tainted, discounted 
one.” Stafford and Scott defined stigma as “a characteristic of persons that is 
contrary to norm of a social unit”, where a norm is defined as “shared belief 
that a person ought to behave in a certain way at a certain time.”  Social 
labeling and social stigma are interrelated. The culmination of stigma process 
occurs when designated differences lead to various forms of disapproval, 
rejection, exclusion and discrimination. Varied dimensions of stigmatized 
medical conditions include the nature of the illness, its history, and attributed 
characteristics; sources of creation and perpetuation of stigma; the nature of the 
population who are perceived to carry the illness; the kind of treatment and 
practitioners sought for the condition; and how individuals with stigmatized 
medical conditions cope with societal insults that endanger their personal 
identity, social life, and economic opportunities. 
 Stigma is inherently integrated in different aspects of Indian life, 
especially with certain diseases. Since time immemorial, tuberculosis, cancer, 
leprosy, and mental illnesses were stigmatizing, until HIV infection became 
prevalent over the last two decades (Santosh K. Chaturvedi et al). 
 HIV – related stigma is multi-layered, tending to build upon and 
reinforce negative connotations through the association of HIV and AIDS with 
already-marginalized behaviours, such as sex work, drug use, and homosexual 
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and transgender sexual practice. It also reinforces fears of outsiders and 
otherwise vulnerable groups, such as prisoners and migrants. Individuals living 
with HIV are often believed to deserve their HIV-positive status as a result of 
having done something ‘wrong’.  
 Stigma is deeply rooted, operated within the values of everyday life. 
Although images associated with AIDS vary, they are patterned so as to ensure 
that AIDS-related stigma plays into, and reinforces, social inequalities.  
 Stigmatization can also occur on another level. People living with HIV 
may themselves internalize the negative responses and reaction of others – a 
process that can result in what some people have called self- or ‘internalized’ 
stigmatization. Self-stigmatization has links to what some writers have 
described as ‘felt’, as opposed to ‘enacted’, stigma, in that it primarily affects 
an individual’s or affected community’s sense of pride and worth. For people 
living with HIV, this may be manifested in feelings of shame, self-blame, and 
worthlessness, which, combined with feelings of being isolated from society, 
can lead to depression, self-imposed withdrawal and even suicidal feelings. 
 Leprosy is probably associated with maximum degree of deformity, 
disability, and social stigma. Because of medical advances, there has been a 
considerable reduction in the stigma in the last 50 years. It is only in the last 
few years, however, that the social dimension is being increasingly recognized 
as critical to the process of rehabilitation of these patients and being 
incorporated into the various leprosy control programs.  
Since the early 1980s, there have been studies on leprosy patients 
emphasizing the presence of psychiatric morbidity. Patients had more negative 
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attitudes toward their illness, most commonly illness evokes public fear and 
hate, illness is degrading and humiliating, they should be segregated from 
society, and illness is incurable and is a consequence of sins. Segregation from 
family (by being inpatients) accentuated the negative attitudes and associated 
stigma. Subsequently, 100 displaced or migratory leprosy patients in a centre in 
North West India were studied for presence of psychiatric morbidity and its 
correlates. A very high prevalence rate was found (76%), depression and 
anxiety being the illnesses encountered. The authors attributed this high 
psychiatric morbidity to the fact that the migrated patients had been stigmatized 
and subjected to rejection. Presence of social support, however, contributed to 
lesser presence of psychiatric morbidity by offering social and emotional 
security. It has been additionally reported that patients with leprosy can be 
subject to two kinds of stigma: social stigma and self-stigma leading into 
socially imposed isolation and self-imposed isolation. 
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AIM AND HYPOTHESIS 
AIM OF THE STUDY 
To compare the psychiatric morbidity between HIV positive patients and 
leprosy patients 
OBJECTIVES 
1) To assess the prevalence of psychiatric morbidity among HIV positive 
and leprosy patients 
2) To study the stigma related to HIV 
HYPOTHESIS 
The following null hypothesis was postulated 
There is no difference in psychiatric morbidity, physical distress and self 
perceived stigma between HIV positive patients and Leprosy patients. 
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MATERIAL AND METHOD 
SETTING  
 The sample was drawn from outpatients attending the Anti Retroviral 
Therapy Clinic (ARV Clinic) and Leprosy Clinic of the Chennai Government 
Medical College, Chennai. 
Patients attending these clinics are referred from various departments 
within the hospital, other centres and the nearby towns. The psychosocial unit 
of the ARV clinic is involved in providing information and education about 
HIV and AIDS for patients. Pretest counseling and posttest counseling are 
offered for the individuals attending the clinic. 
DESIGN  
 Case Control Study design. 
RECRUITMENT  
 Thirty one (31) HIV positive and thirty (30) leprosy patients, attending 
the ART clinic and Leprosy clinic respectively, who satisfied the inclusion 
criteria for the study were selected.  
HIV infection was diagnosed by ELISA as per WHO guidelines. 
Leprosy infection was diagnosed by clinical examination as well as skin biopsy 
test. 
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Inclusion criteria for cases 
1)  Age between 18 and 60 yrs  
2)  Definitive diagnosis of HIV infection  
3)  Informed Consent  
Inclusion criteria for controls 
1)  Age between 18 and 60 yrs 
2)  Definitive diagnosis of Leprosy 
3)  Informed Consent 
Exclusion criteria for cases 
1)  Patients with mental and physical illness of such severity so as to 
preclude the interview  
2)  Those patients who were unwilling or could not understand the 
information required to give consent to the study. 
Exclusion criteria for controls 
1)  Patients with mental and physical illness of such severity so as to 
preclude the interview  
2)  Those patients who were unwilling or could not understand the 
information required to give consent to the study. 
 27
Data Collection  
The following instruments were employed to collect the data  
1. A semi – structured proforma to collect the socio demographic details 
and psychiatric history (appendix – 1) 
2. ICD – 10 Clinical and Diagnostic Criteria 
3. Hamilton Rating Scale for Anxiety (HAM A) (Appendix – 2) 
4. Beck Depression Inventory (BDI) (Appendix – 3) 
5. Beck scale for suicidal ideation (BSS) (Appendix – 4) 
6. Montgomery Asberg Depression Rating scale (MADRS) (Appendix – 5) 
1.  Semi structured Proforma  
Information was collected regarding the following  
a. Sociodemographic data – includes hospital number, age, sex, marital 
status, religion, occupation, education, socioeconomic status, social 
support, time interval between HIV diagnosis and assessment, time 
interval between leprosy diagnosis and assessment. 
b. Clinical characteristics - information regarding current psychiatric 
diagnosis, past psychiatric history, family history and suicidality were 
entered. 
c. Physical Distress – relating to impairment due to physical alignment or 
illness. 
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d. Self – Perceived Stigma – a 3 item Likert scale was constructed to assess 
the individual perception of the stigmatizing nature of the HIV and 
leprosy infection. 
e. The proforma contained the same items for both cases and controls, 
except that the one for cases included CD4+ cell count, VDRL test 
status and HIV status of spouse. 
2.   ICD – 10 Clinical and diagnostic criteria. 
This was used to diagnose current and past psychiatric morbidity. 
3.   Hamilton Rating scale for Anxiety (HAM – A) 
This 14-item scale is the most widely used scale for anxiety. Scores on 
individual items range from 0-4, with a total score of 56, with a final item 
which rates behaviours at interview.  
4.   Beck Depression Inventory (BDI) 
This 21-item self rating sale is a well established, widely used inventory of 
the cognitive, affective, motivational and somatic symptoms of depression. 
Scores on individual items range from 0-3 with a total score of 63 
  0 -  9   minimal  
10- 16  mild depression  
17- 29  moderate depression  
   > 30  severe depression  
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5.   Beck Scale for Suicide Ideation (BSS) 
This is a 21 item scale with scores ranging from 0-2 on individual items 
(items 20 and 21 are not included in the total score). Thus the possible range of 
score is 0-38. The scale for suicidal ideation was designed to quantify the 
intensity of current conscious suicidal intent by measuring self destructive 
thoughts or wishes. The scale is divided into 5 sections 
a.  Characteristics of attitude towards living/dying 
b.  Characteristic of suicidal ideation/ wish 
c.  Characteristic of contemplated attempt  
d.  Actualization of attempt contemplated  
e.  Background factors  
6.  Montgomery – Asberg Depression Rating scale (MADRS) 
The MADRS, developed by S.A Montgomery and M. Asberg, is a rating 
scale for the assessment of depression which was drawn from the 
comprehensive psychopathological rating scale. 
The MADRS consists of 10 items that are all core symptoms of 
depression. Nine of the items are based upon patient report and one on the 
rater’s observation.  Items of the scale are rated on a 0-6 scale. 
Unlike the more commonly utilized HAM-D, MADRS does not focus 
predominantly on the somatic symptoms of depression, but rather focuses on 
symptoms such as sadness, tension, lassitude, pessimistic thoughts and suicidal 
thoughts. 
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Procedure  
The study was conducted over a period of 3 months. Informed consent 
was obtained from each subject prior to interview and subjects assured of 
confidentiality.  
The project was discussed and approved by the Ethical Committee of the 
Madras Medical College.  
31 HIV positive patients receiving ambulatory care at ART Clinic of the 
Government General Hospital, Chennai and 30 leprosy patients receiving 
ambulatory care at Leprosy Clinic of the Government General Hospital, 
Chennai were selected who fulfilled the inclusion criteria of the study. 
Information for the study was obtained from the patients and hospital records. 
Each patient underwent a semi-structured clinical interview and 
psychiatric morbidity, if present, was diagnosed based on ICD – 10 Clinical 
and Diagnostic Criteria. Information obtained from each patient was then 
entered into semi structured proforma. Current Anxiety was measured by 
Hamilton Rating Scale for Anxiety. Depression was measured by Beck 
Depression Inventory and Montgomery Asberg Depression Rating Scale. Beck 
Scale for Suicidal Ideation measured suicidal ideation during the week 
preceding the interview. 
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STATISTICAL ANALYSIS 
First using Epi 6 info (WHO and CDC, Atlanta) software frequency 
distribution of all variables that were collected during the study was obtained. 
The two groups of cases and controls were compared for and univariate 
analysis was carried out using SPSS version 15 (SPSS Inc.,). Chi square test 
was used for the qualitative variables and Anova was performed for 
quantitative variables. The test of significance was fixed at p < 0.05.  
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RESULTS 
 
Table 1   
Socio-demographic characteristics of cases (N = 31) 
Variables N Percentage (%) 
95 % Confidence 
Interval (C. I) 
   
25 80.6 62.5, 92.5 
Sex 
    Male 
    Female 
6 19.4 7.5, 37.5 
   
6 19.4 7.5,37.5 
22 71.0 52,85.5 
1 32.0 0.1,16.7 
Education 
    Primary 
    Secondary 
    Higher 
secondary 
    College 2 6.5 0.8,21.4 
   
27 87.1 70.2, 96.4 
Occupation 
    Employed 
    Unemployed 
4 12.9 3.6, 29.2 
   
18 58.1 39.1, 75.5 
11 35.5 19.2, 54.6 
Economic 
    Low 
    Middle 
    High 
2 6.5 0.8, 21.4 
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The average age of the cases was 33.7 (S.D. 6.5), most were males 
(80%), majority of them had attained secondary level of education and 
predominantly belonged to low and middle economic status. 
 
 
Variables N % 95 % C.I. 
   
15 48.4 30.2, 66.9 
Region 
    Urban 
    Rural 
16 51.6 33.1, 69.8 
Marital Status    
    Married 13 41.9 24.5, 60.9 
    Unmarried 11 35.5 19.2, 54.6 
    Divorced 1 3.2 0.1, 16.7 
    Widow 3 9.7 2.0, 25.5 
    Separated 3 9.7 2.0, 25.8 
Social Support    
    Poor 11 35.5 19.2, 54.6 
    Moderate 16 51.6 33.1, 69.8 
    Good 4 12.9 3.6, 29.8 
 N Mean Standard 
Deviation 
Age 31 33.74 6.54 
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Table 2 
Sociodemographic characteristics of Controls (n = 30) 
Variables N Percentage (%) 95 % Confidence Interval (C. I) 
  
24 80 61.4, 92.3
  Sex 
    Male 
    Female 
6 20 7.7, 38.6
  
12 40 22.7, 59.4
13 43.3 22.5, 62.6
2 6.7 0.8, 22.1
Education 
    Primary 
    Secondary 
    Higher secondary 
    College 
3 10 2.1, 26.5
  
23 76.1 57.7, 90
Occupation 
    Employed 
    Unemployed 
7 23.3 9.9, 42.2
  
20 66.7 47.2, 82.7
10 33.3 17.3, 52.8
Economic 
    Low 
    Middle 
    High 
0 0 0.0, 11.6
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Variables N Percentage (%) 95 % Confidence 
Interval (C. I) 
   
17 56.7 37.4, 74.5 
Region 
    Urban 
    Rural 
13 43.3 25.5, 62.6 
Marital Status    
    Married 16 53.3 34.3, 71.7 
    Unmarried 11 36.7 19.9, 56.1 
    Divorced 0 0 0, 11.6 
    Widow 3 10 2.1, 26.5 
    Separated 0 0 0, 11.6 
Social Support    
    Poor 9 30 14.7, 49.4 
    Moderate 14 46.7 28.3, 65.7 
    Good 7 23.3 9.9, 42.3 
 N Mean Standard 
Deviation 
Age 30 39.53 13.08 
 
 The average age of the controls was 39.5 (S.D. 13.1), most were males 
(80%), majority of them had attained secondary level of education and 
predominantly belonged to low and middle economic status. 
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Table 3 
Psychiatric features in Cases (n = 31) 
 
Variable N % 
Current psychiatric diagnosis   
    No diagnosis 16 51.6 
    Depressive Episode 5 16.2 
    Adjustment Disorder 3 9.7 
    Alcohol Dependence 4 12.9 
Mixed Anxiety and Depression 2 6.5 
Past psychiatric morbidity   
    Absent 23 74.2 
    Present 8 25.8 
Family h/o psychiatric illness   
   Absent 23 74.2 
   Present 8 25.8 
 
 Current psychiatric diagnosis was present in 48.4 % of the sample. 
Depression and Alcohol dependence were the two most common diagnoses. 
Past psychiatric morbidity and family history of psychiatric morbidity were 
present in about 25 % of the sample each. 
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Table 4  
Psychiatric features in Controls (n = 30) 
Variable N % 
Current psychiatric diagnosis   
    No diagnosis 15 50 
    Depressive Episode 4 13.3 
    Dysthymia 2 6.6 
    Alcohol Dependence 3 10 
    Generalized Anxiety Disorder 1 3.3 
Mixed Anxiety and Depression 1 3.3 
    Adjustment Disorder 4 13.3 
Past psychiatric morbidity   
    Absent 26 86.7 
    Present 4 13.3 
Family h/o psychiatric illness   
  Absent 28 93.3 
   Present 2 6.7 
 
 Diagnosable psychiatric disorder was made out in 50 % of the controls, 
with Depression, Adjustment disorder and Alcohol dependence being most 
common.  
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Table 5 
Physical Distress of Cases (n = 31) 
Physical Distress N % 95 % C.I. 
    Absent 27 87.1 70.2, 96.4 
    Present 4 12.9 3.6, 29.8 
 
 
 Around 13 % of the cases exhibited physical distress, as measured by 
pain and disability. 
Table 6 
Physical Distress of Controls (n = 30) 
 
Physical Distress N % 95 % C.I. 
    Absent 10 33.3 17.3, 52.8 
    Present 20 66.7 47.2, 82.7 
 
Around 67 % of the controls exhibited physical distress, as measured by 
pain, disability and disfigurement. 
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Table 7 
Perception of Stigma in Cases (n = 31) 
 
Perception N % 
    Agree 28 90.32 
    Don’t know 2 6.45 
    Disagree 1 3.23 
 
 Around 90 % of the cases accepted to a perception of stigma. 
 
Table 8 
Perception of Stigma in Controls (n = 30) 
Perception N % 
    Agree 19 63.34 
    Don’t know 9 30 
    Disagree 2 6.66 
 
 Around 63 % of the controls accepted to a perception of stigma. 
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Table 9  
Scores on scales for cases (n = 31) 
Scale Mean score Standard Deviation 
BDI 5.0645 9.0146 
MADRS 4.3871 9.0799 
BSS 2.032 5.5707 
HAM A 3.5161 6.4491 
  
The mean score on BDI was 5.06 (S.D. 9.04). The mean score of 
MADRS was 4.38 (S.D. 9.07). The mean score on BSS was 2.03 (S.D. 5.57). 
The mean score on HAM A was 3.51 (S.D. 6.44). 
Table 10  
Scores on scales for controls (n = 30) 
Scale Mean score Standard Deviation 
BDI 5.1667 5.1063 
MADRS 3.800 4.082 
BSS 0.700 1.7840 
HAM A 4.200 4.6786 
 
The mean score on BDI was 5.16 (S.D. 5.1). The mean score of 
MADRS was 3.80 (S.D. 4.08). The mean score on BSS was 0.07 (S.D. 1.78). 
The mean score on HAM A was 4.2 (S.D. 4.67). 
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COMPARATIVE DATA 
 
The groups were compared for the following variables: 
1. Sociodemographic variables 
2. Psychiatric characteristics 
3. Physical Distress 
4. Perception of stigma 
5. Scores on BDI,MADRS, BSS, HAM A 
 
Table 11 
Comparison of Sex distribution of cases and controls 
 
Sex  
Female Male 
Total 
Cases 6 25 31 
Controls 6 24 30 
Total 12 49 61 
 
 Value df p  value 
Pearson Chi-Square 0.004 1 0.949 
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Table 12 
Comparison of Educational status of cases and controls 
 
Educational Status   
Primary Secondary Higher 
Secondary 
College Total 
Cases 6 22 1 2 31 
Controls 12 13 2 3 30 
Total 18 35 3 5 61 
 
 Value df p  value 
Pearson Chi-Square 4.833 3 0.184 
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Table 13 
Comparison of Occupational status of cases and controls 
 
 Occupational Status 
 Unemployed Employed 
Total 
Cases 4 27 31 
Controls 7 23 30 
Total 11 50 61 
 
 
 Value df p  value 
Pearson Chi-Square 1.122 1 0.289 
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Table 14 
Comparison of Economic status of cases and controls 
 Economic Status 
 Low Middle High 
Total 
Cases 18 11 2 31 
Controls 20 10 0 30 
Total 38 21 2 61 
 
 Value df p  value 
Pearson Chi-Square 2.137 2 0.344 
 
 
 
 
 
 
 
 
 
 
 
 45
 
 
 
 
Table 15 
Comparison of regional background of cases and controls 
Region  
Urban Rural 
Total 
Cases 15 16 31 
Controls 17 13 30 
Total 32 29 61 
 
 Value df p  value 
Pearson Chi-Square 0.419 1 0.517 
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Table 16 
Comparison of Marital status of cases and controls 
Marital Status  
Married Unmarried Divorced Widow Separated 
Total 
Cases 13 11 1 3 3 31 
Controls 16 11 0 3 0 30 
Total 29 22 1 6 3 61 
 
 Value df p  value 
Pearson Chi-Square 4.295 4 0.368 
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Table 17 
Comparison of Social support of cases and controls 
Social support  
Poor Moderate Good 
Total 
Cases 11 16 4 31 
Controls 9 14 7 30 
Total 20 30 11 61 
 
 Value df p  value 
Pearson Chi-Square 1.135 2 0.567 
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Table 18 
Comparison of Age distribution of cases and controls 
 
 Sum of 
squares 
df Mean square F Sig. 
Between groups 7.796 28 0.278 1.196 0.311 
Within groups 7.45 32 0.233   
Total 15.25 60    
  
 
Tables 11 to 18 show the comparison of Sociodemographic tables 
between the cases and controls. There is no statistically significant difference in 
Sociodemographic variables between cases and controls. 
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Table 19 
Comparison of Current Psychiatric diagnosis of cases and controls 
 
Current Psychiatric Diagnosis  
Absent Present 
Total 
Cases 16 15 31 
Controls 15 15 30 
Total 31 30 61 
 
 Value df p  value 
Pearson Chi-Square 0.016 1 0.90 
  
There is no statistically significant difference in current psychiatric 
diagnosis between cases and controls. 
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Table 20 
Comparison of Past Psychiatric morbidity of cases and controls 
 
Past Psychiatric morbidity  
Absent Present 
Total 
Cases 23 8 31 
Controls 26 4 30 
Total 49 12 61 
 
 Value df p  value 
Pearson Chi-Square 1.501 1 0.221 
 
 There is no statistically significant difference in past psychiatric 
morbidity between cases and controls. 
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Table 21 
Comparison of Family history of psychiatric morbidity  
of cases and controls 
Family history of psychiatric 
morbidity 
 
Absent Present 
Total 
Cases 23 8 31 
Controls 28 2 30 
Total 51 10 61 
 
 Value df p  value 
Pearson Chi-Square 4.075 1 0.044 
 
 The difference in family history of psychiatric morbidity between cases 
and controls is statistically significant (p < 0.05). 
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Table 22 
Comparison of Physical Distress of cases and controls 
 
Physical Distress  
 Absent Present 
Total 
Cases 27 4 31 
Controls 10 20 30 
Total 37 24 61 
 
 Value df p  value 
Pearson Chi-Square 18.466 1 0.00 
 
 There is a statistically significant difference in the presence of physical 
distress between cases and controls. Among controls, 20 (66.7%) had physical 
distress as compared to 4 (12.9%) among the cases. This could possibly be 
because of the effect leprosy has on the peripheral nerves. 
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Table 23 
Comparison of Perception of Stigma of cases and controls 
Perception of Stigma  
Strongly agree/ 
Agree 
Others Total 
Cases 28 3 31 
Controls 19 11 30 
Total 21 26 61 
 
 Value df p  value 
Pearson Chi-Square 6.18 1 0.0123 
 
The two groups differed in the perception of stigma and the difference 
was statistically significant (p = 0.01). Most of the HIV positive patients 
(90.3%) agreed that they perceived stigma compared with 63.3% of leprosy 
patients.  
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Table 24 
Comparison of scores on BDI 
 
 Sum of 
squares Df 
Mean 
Square F Sig. 
BDI 6.525 18 0.363 1.746 0.069 
 
 There is no statistically significant difference between cases and controls 
in scores on BDI. 
Table 25 
Comparison of scores on MADRS 
 
 Sum of 
squares 
Df Mean 
Square 
F Sig. 
MADRS 7.704 16 0.482 2.809 0.003 
 
 There is a statistically significant difference in scores on MADRS 
between cases and controls. 
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Table 26 
Comparison of scores on BSS 
 
 Sum of 
squares 
Df Mean 
Square 
F Sig. 
SSI 2.079 7 0.297 1.196 0.321 
 
 There is no statistically significant difference between cases and controls 
in scores on BSS. 
 
Table 27 
Comparison of scores on HAM A 
 
 Sum of 
squares 
Df Mean 
Square 
F Sig. 
HAM A 4.413 15 0.294 1.222 0.291 
 
There is no statistically significant difference between cases and controls 
in scores on HAM A. 
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DISCUSSION 
 The study was done using a case-control design. The cases comprised of 
HIV positive patients attending outpatient clinic of the general hospital, 
Chennai. The control group of patients was patients suffering from Hansen’s 
disease attending the outpatient clinic of the same tertiary hospital. The 
controls were selected from patients suffering from Leprosy as these two 
diseases that are being examined are the ones subjected to stigma, 
marginalization and ostracization from communities.  
SOCIODEMOGRAPHIC FEATURES 
 Most studies done on HIV/AIDS patients have focused on specific 
group e.g. homosexual men (Kelly et al, 1998), female military personnel 
(Rabkin et al, 1992) and AIDS patients (Rabkin et al, 1997). Most studies done 
on leprosy patients have focused on those residing in rehabilitation centres 
(K.K. Verma et al, 1994) and Leprosy hospitals (Henry Oliver M.D. 1987). 
This study was done on patients attending the outpatient department. The mean 
age of HIV group was 33.7 years, indicative of the prevalence of infection 
among the younger age group. The study group had a low percentage of 
females; this could be due to the reluctance among the female HIV patients in 
giving informed consent for the study. The majority were from low 
socioeconomic group. This could be due to the fact that majority of the patients 
attending the general hospital services hail from the low socio economic group. 
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CLINICAL FEATURES 
 The prevalence of psychiatric morbidity was 48.4% among the cases 
(HIV patients) and 50 % among the controls. The prevalence of psychiatric 
morbidity in the study group is similar to the findings from the study done by 
Priya Mary Mammen in CMC, Vellore (2002) and is similar to the study by 
Lyketsos et al, 1994 which found a psychiatric morbidity of 54% among HIV 
positive patients attending the outpatient clinic. 
 The prevalence of psychiatric morbidity among the leprosy patients is 
similar to the result found by Mitchell Gweiss et al, 1992(50 %). 
 Among those HIV patients with psychiatric morbidity, the most 
common diagnosis was depression. The rate of depressive disorder detected in 
the present study is 16.2 %. This is similar to the finding of Perry and Tross 
(1984) who found a prevalence rate of major depression of 17.3 % in their 
sample, although their sample consisted of admitted AIDS patients. This is also 
similar to the finding by Priya Mary Mammen who found a prevalence rate of 
major depression of 14.5% in their sample of outpatients. 
 The rate of Alcohol Dependence found in this study was 12.9 % which 
is midway to the prevalence rates found in other studies. For example, Lyketsos 
et al 1994 found a prevalence of 22% while the prevalence in the study by 
Priya Mary Mammen was 6 %. The prevalence of adjustment disorder in our 
study was 9.7 %. 
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 The leprosy patients group had a prevalence of depression of 16.6 % 
while that of Dysthymia was 6.6 %. This finding correlates with the study by 
Mitchell Gweiss et al, 1992, which showed a prevalence of major depression of 
17.9 % and 3.6 % of Dysthymia among patients with leprosy. 
 The two groups of patients – HIV positive and the leprosy patients were 
comparable for all the socio-economic characteristics. A comparison was made 
between the two groups for all the relevant variables – psychiatric history, 
physical distress and perception of stigma.  The two groups did not differ with 
regards to the prevalence of psychiatric morbidity as observed through clinical 
examination. The family history of psychiatric illness was more among the 
HIV positive patients compared with the leprosy patients. There was difference 
in the mean total scores obtained from MADRS and this difference means that 
the HIV positive patients exhibit more depressive symptoms compared with the 
leprosy patients. The two groups differed significantly in their perception of 
stigma. As most HIV positive patients express overt stigma, this needs to be 
addressed. This perception of stigma as well explains the more depressive 
symptomatology (not amounting to clinical syndrome) observed among the 
HIV positive patients.  
This study and its implications are important for the following two 
reasons. First, it is worth investigating the psychiatric morbidity of the HIV 
positive patients. Depression is the most important psychiatric morbidity 
followed by alcohol dependence. While organizing mental health services for 
the HIV positive patients this factor should be considered. Depression is 
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eminently identifiable and more importantly treatable. Early identification and 
treatment of depression would certainly improve the quality of life of HIV 
positive individuals. Furthermore, depression among HIV positive individuals 
interferes with adherence to HIV treatment. Treating depression adequately is a 
sure way to improve adherence with treatment. Alcohol use among the HIV 
positive patients is detrimental to their health. Alcohol facilitates HIV diseases 
progression. Further, dependent individuals lead a chaotic life style that will 
interfere with their compliance to treatment. Alcohol use should be routinely 
screened and those with alcohol use disorders should be identified and helped 
at the earliest. 
Second, the study has demonstrated that the HIV positive patients suffer 
from stigma even more than patients with leprosy. If in yesteryears leprosy was 
the most stigmatized condition, at the present times, unfortunately, stigma 
seems to be the greatest threat for individuals with HIV infection. Despite the 
fact that HIV disease is a chronic manageable condition for which evidence 
based effective medications are available (free treatment through Government 
hospitals), still stigma surrounds this condition markedly. Addressing and 
defeating the stigma is vital. Tackling HIV-related stigma, discrimination and 
human rights violations is critical in slowing the impact of the epidemic. 
Stigma and discrimination impact negatively on every aspect of the prevention-
care-treatment continuum, as well as greatly increasing the suffering associated 
with living with HIV.  Stigma, discrimination and human rights violations are 
intimately linked, reinforcing and legitimizing each other. Multifaceted action, 
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sustained over time, is needed to prevent stigma, challenge discrimination 
when it occurs in specific settings, and promote and protect HIV-related human 
rights. There is an urgent need to integrate anti-stigma and antidiscrimination 
elements more consistently and explicitly into AIDS programming practice 
than is currently the case. Community based programs to specifically address 
the stigma is critical.  The HIV positive persons’ networks have been highly 
successful in organizing community based efforts to defeat stigma and such 
activities should be scaled up.  With experience of dealing with mental illness-
related stigma, mental health professionals are ideally suited to deal with HIV 
related stigma. 
 61
LIMITATIONS 
1. The sample was drawn from patients attending a large tertiary hospital. 
The finding observed, therefore, cannot be generalized to the 
community. 
2. Small size of the sample. 
3. 80 % of the sample was males. 
4. Patients with mental or physical illness of such severity so as to preclude 
the assessment had to be excluded from the study. This may influence 
the prevalence rate. 
5. Personality factors were not assessed. 
6. Relatives were not interviewed. 
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CONCLUSION 
 
The study using a case control design compared the HIV positive 
patients and leprosy patients – two chronic medical conditions that are 
subjected to social stigma. The study examined and compared the prevalence of 
psychiatric morbidity, physical distress and perception of stigma between the 
two groups. Depression was the most common psychiatric morbidity among 
HIV positive patients (16%) followed by alcohol dependence (13%). Compared 
with the group of leprosy patients HIV positive patients differed in the 
following: 
1) The mean total scores obtained through MADRS was high among the 
HIV positive patients compared with the leprosy patients (p =0.003) 
2) The family history of psychiatric morbidity was more among the HIV 
positive patients compared with the leprosy patients (P < 0.05) 
3) The physical distress was higher among the leprosy patients compared 
with the HIV positive patients (p <0.001) 
4) The perception of stigma was greater in among the HIV positive patients 
compared with the leprosy patients (P = 0.01) 
It is important to identify and treat depression and alcohol dependence 
among the HIV positive patients as these two conditions also interfere with the 
HIV treatment adherence. Moreover both these clinical conditions can have 
significant negative impact on disability, quality of life and economic 
productivity. Stigma and discrimination should be urgently addressed in all 
HIV care programs. Involvement of HIV positive networks and community 
programs to address stigma are vital. Mental health professionals can play an 
important role in HIV-related stigma reduction programs.  
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APPENDIX 1 
 
SEMI STRUCTURED PROFORMA 
 
1. Date of assessment 
2. Date of diagnosis 
3. Time interval (between the diagnosis of the disease and assessment) 
4. Received pre test counseling 
5. Received post test counseling 
6. Socio demographic data 
1) Name 
2) Age 
3) Sex (male/female) 
4) Marital status (married/single/divorced/widow) 
5) Religion (Hindu/Christian/Muslim, others) 
6) Occupation (employed/unemployed) 
7) Region (rural/urban) 
8) Education (primary, secondary, higher secondary, college) 
9) Socio economic status (low, middle, high) 
10) Social support (poor/moderate/good) 
7. HIV status of the spouse 
8. Mode of transmission 
9. Current psychiatric diagnoses 
10. Past history (psychiatric diagnoses; absent/present) 
11. Family history (psychiatric diagnoses; absent/present) 
12. Physical distress (pain/disability/disfigurement) 
13. Perception of HIV stigma (agree/disagree/don’t know) 
14. CD4 count 
15. VDRL Test 
APPENDIX - 2 
HAMILTON ANXIETY SCALE 
Patient Name         Date  : 
 
0 = absent      1  = Mild 
2 = Moderate     3 = Severe 
4 = Very severe, Grossly disabling 
Answer every question  by entering numeral in appropriate box Score 
ANXIOUS MOOD 
Worries, anticipation of the worst, fearful anticipation, irritability 
 
TENSION 
Feeling of tension, fatiguability, startle response, moved to tears easily, 
tremling, feeling of restlessness, inaility to relax 
 
FEARS 
Of dark, of strangers, of being left alone, of animals, of traffic, or crowds. 
 
INSOMNIA 
Difficulty in falling asleep, broken sleep, unsatisfying sleep and fatigue on 
walking, dreams, nightmares, night terros 
 
INTELLECTUAL 
Difficulty in concentration, poor memory 
 
INTELLECTUAL 
Difficulty in concentration, poor memory 
 
DEPRESSED MOOD 
Loss of interest, lack of pleasure in hobbies, depression, early walking diurnal 
swing. 
 
SOMATIC (Muscular) 
Pain and aches, twitchings, stiffness, myoclonic jerks, grinding of teeth, 
unsteady voice, increased muscular tone 
 
SOMATIC (Sensory) 
Tinnitus, bluring vision, hot and cold flushes, feelings of weakness, pricking 
sensation. 
 
CARDIOVASCULAR SYMPTOMS 
Tacycardia, palpitations, pain in chest, throbbing of vessels, fainting feelings, 
sighing dysnpoea.  
 
RESPIRATORY SYMPTOMS 
Pressure of constriction in chest, choking feelings, sighing, dyspnoea 
 
GASTROINTESTINAL SYMPTOMS 
Difficulty in swallowing, wind, abdominal pain. burning sensations, abdominal 
fullness, nausea, vomitting, borborygmi, looseness of bowels, loss of weight, 
constipation.  
 
GENITOURINARY SYMPTOMS 
Frequency of micturition, urgency of micturition, amenorrhoea, menorrhagia, 
development of frigidity, premature ejaculation, loss of libido, impotence 
 
AUTONOMIC SYMPTOMS 
Dry mout, flushing, pallor, tendency to sweat, giddiness, tension headahe, 
raising of hair 
 
BEHEAVIOUR AT INTERVIEW  
Fidgeting, restlessness or pacing, tremor of hands, furrowed brow, strained 
face, sighing or rapid respiration, facial pallor, swallowing etc.  
 
TOTAL  
APPENDIX 3 
BECK’S DEPRESSION INVENTORY 
1. Sadness 
0 I do not feel sad. 
1 I feel sad 
2 I am sad all the time and I can't snap out of it. 
3 I am so sad and unhappy that I can't stand it.  
2. Pessimism 
0 I am not particularly discouraged about the future. 
1 I feel discouraged about the future. 
2 I feel I have nothing to look forward to. 
3 I feel the future is hopeless and that things cannot improve.  
3. Sense of failure 
0 I do not feel like a failure. 
1 I feel I have failed more than the average person. 
2 As I look back on my life, all I can see is a lot of failures. 
3 I feel I am a complete failure as a person.  
4. Dissatisfaction 
0 I get as much satisfaction out of things as I used to. 
1 I don't enjoy things the way I used to. 
2 I don't get real satisfaction out of anything anymore. 
3 I am dissatisfied or bored with everything.  
5. Guilt  
0 I don't feel particularly guilty 
1 I feel guilty a good part of the time. 
2 I feel quite guilty most of the time. 
3 I feel guilty all of the time.  
6. Expectation of punishment 
0 I don't feel I am being punished. 
1 I feel I may be punished. 
2 I expect to be punished. 
3 I feel I am being punished.  
7. Dislike of self  
0 I don't feel disappointed in myself. 
1 I am disappointed in myself. 
2 I am disgusted with myself. 
3 I hate myself.  
8. Self Accusation 
0 I don't feel I am any worse than anybody else. 
1 I am critical of myself for my weaknesses or mistakes. 
2 I blame myself all the time for my faults. 
3 I blame myself for everything bad that happens.  
9. Suicidal ideation 
0 I don't have any thoughts of killing myself. 
1 I have thoughts of killing myself, but I would not carry them out. 
2 I would like to kill myself.  
3 I would kill myself if I had the chance.  
10. Episodes of crying 
0 I don't cry any more than usual. 
1 I cry more now than I used to. 
2 I cry all the time now. 
3 I used to be able to cry, but now I can't cry even though I want to.  
11. Irritability 
0 I am no more irritated by things than I ever was. 
1 I am slightly more irritated now than usual. 
2 I am quite annoyed or irritated a good deal of the time. 
3 I feel irritated all the time.  
12. Social withdrawal 
0 I have not lost interest in other people. 
1 I am less interested in other people than I used to be. 
2 I have lost most of my interest in other people. 
3 I have lost all of my interest in other people.  
13. Indecisiveness 
0 I make decisions about as well as I ever could. 
1 I put off making decisions more than I used to. 
2 I have greater difficulty in making decisions more than I used to. 
3 I can't make decisions at all anymore.  
14. Change in body image 
0 I don't feel that I look any worse than I used to. 
1 I am worried that I am looking old or unattractive. 
2 I feel that there are permanent changes in my appearance that make me look 
unattractive. 
3 I believe that I look ugly.  
15. Retardation 
0 I can work about as well as before. 
1 It takes an extra effort to get started at doing something. 
2 I have to push myself very hard to do anything. 
3 I can't do any work at all.  
16. Insomnia 
0 I can sleep as well as usual. 
1 I don't sleep as well as I used to. 
2 I wake up 1-2 hours earlier than usual and find it hard to get back to sleep. 
3 I wake up several hours earlier than I used to and cannot get back to sleep.  
17. Fatigability 
0 I don't get more tired than usual. 
1 I get tired more easily than I used to. 
2 I get tired from doing almost anything. 
3 I am too tired to do anything.  
18. Loss of appetite 
0 My appetite is no worse than usual. 
1 My appetite is not as good as it used to be. 
2 My appetite is much worse now. 
3 I have no appetite at all anymore.  
19. Loss of Weight 
0 I haven't lost much weight, if any, lately. 
1 I have lost more than five pounds. 
2 I have lost more than ten pounds. 
3 I have lost more than fifteen pounds.  
20. Somatic preoccupation 
0 I am no more worried about my health than usual. 
1 I am worried about physical problems such as aches and pains, or upset 
stomach, or constipation. 
2 I am very worried about physical problems and it's hard to think of much 
else. 
3 I am so worried about my physical problems that I cannot think about 
anything else.  
21. Low level of energy 
0 I have not noticed any recent change in my interest in sex. 
1 I am less interested in sex than I used to be. 
2 I have almost no interest in sex. 
3 I have lost interest in sex completely.  
INTERPRETATION OF THE BECK DEPRESSION INVENTORY  
Total Score____________________Levels of Depression  
1-10____________________These ups and downs are considered normal  
11-16___________________ Mild mood disturbance  
17-20___________________Borderline clinical depression  
21-30___________________Moderate depression  
31-40___________________Severe depression  
over 40__________________Extreme depression  
 
APPENDIX- IV 
 
 BECK'S SCALE FOR SUICIDE IDEATION 
 
I. Characteristics of attitude toward living / dying 
1. ÁõÇ Â¸¨£®  
0 _©õµõP C¸UQÓx (KµÍÄUS C¸UQÓx) AÀ»x EÖv¯õP 
C¸UQÓx.  
1. Â¸¨£® £»ÃÚ©õP C¸UQÓx (öPõg\®) 
2. Â¸¨£÷© CÀø» 
 
2. \õP Â¸¨£®  
 0 GxÄ® CÀø» 
 1. öPõg\® EÒÍx 
 2. EÖv¯õÚ Â¸¨£®  
 
3. ÁõÇ/ \õP Põµn[PÒ 
0 ÁõÇ C¸US® Põµn[PÒ \õÁuØPõÚ Põµn[PøÍ Âh AvP 
PÚ©õÚøÁ.  
1. ÁõÇÄ®, \õPÄ® C¸US® Põµn[PÒ \© AÍÁõÚøÁ 
2. \õÁuØPÚ Põµn[PÒ, ÁõÇ C¸US® Põµn[PøÍ Âh AvP 
PÚ©õÚøÁ.  
  
4. _¯¬¯Ø]°À uØöPõø» ö\´x öPõÒÍ÷Ásk® GßÓ BÁÀ (Bø\) 
 0 GxÁ® CÀø» 
 1. £»ÃÚ©õP  EÒÍx 
2. ªu©õP AÀ»x EÖv¯õP C¸UQÓx.  
 
5. uõÚõP ¬¯Ø] ö\´x uØöPõø» ö\´x öPõÒÍõÂmhõ¾®, B£zuõÚ 
`Ì|ø»PÎ¼¸¢x  ußøÚ PõzxU öPõÒÍõ©À C¸¨£vÀ Dk£õk.  
 0 ÁõÌUøPø¯U Põ¨£ØÔU öPõÒÍ ÷Ási¯ ¬ßöÚa\¶UøP²hß 
C¸zuÀ  
1. ÁõÌÄ / \õÄ BQ¯ÁØøÓ Âv°ß £õÀ ÂkuÀ (Euõµn® ) \õø»ø¯U 
PhUS® ÷£õx A»m]¯©õP C¸zuÀ  
2. ÁõÌÁuØS AÁ]¯©Ú ]» ¬¯Ø]PøÍ ö\´¯õ©À C¸¨£x (Euõµn®) 
\ºUPøµ Â¯õvUPõµº Cß_¼ß F] GkUPõ©À C¸¨£x.  
II. Characteristics of suicide ideation wish 
6. GÆÁÍÄ ÷{µ® C¸UQÓx? 
0. AÆÁ¨÷£õx  Á¢x ÷£õS® Gsn® ªPU SøÓ¢u ÷{µ® ©mk®.  
 1. }sh ÷{µ[PÐUS A¢u Gsn® (|øÓ¯) C¸UQÓx.  
 2. öuõhº¢x AÀ»x HÓzuõÇ öuõhº¢x C¸US® Gsn®  
  
7. Frequency  
 0. C¢u Gsn®  A§ºÁ©õP Á¸®  
 1. AÆÁ¨÷£õx Á¸®  
 2. öuõhº¢x C¸UQÓx.  
 
8. Attitude towards ideation 
0 C¢u Gsnzøu ©Úv¼¸¢x APØÔ ÂkÃºPÍõ? (APØÔ ÂkÁx) 
 1. uØöPõø» Gsnzøu¨ £ØÔ G¢u ¬iÄ® CÀ»õv¸zuÀ  
 2. A¢u Gsnzøu HØÖU öPõÒÁx 
9. uØöPõø» ö\¯À «x C¸US® Pmk¨£õk 
 0. Gsnzøu Pmk¨£kzu C¯¾® 
 1. Pmk¨kzu ¬i²® Gß£x \¶¯õPz öu¶¯ÂÀø» 
 2. Pmk¨£õk CÀø» 
 
10. uØöPõø» ö\´x öPõÒÁøuz ukUPU Ti¯ Põµn[PÒ  (E®) Sk®£®, 
©u®  
 ¬¯Ø] ÷uõÀÂ¯øh¢uõÀ Sn©õP ¬i¯õu FÚ® |µ¢uµ©õQ Âk÷©õ 
GßÓ £¯®  
0 C¨£iö¯õ¸  Põµn® C¸¨£uõÀ uØöPõø»US ¬¯Ø] ö\´¯¨ 
÷£õÁvÀø».  
1. CUPõµn[PÒ SÔzxU PÁø» CÀø» 
2. CUPõµn[PøÍ¨ £ØÔU PÁø» CÀø». C¨£i HuõÁx Põµn[PÒ 
C¸¢uõÀ Aøu¨ £ØÔU TÓÄ® 
3. öPõg\® PÁø» C¸UQÓx.  
 
11. ÷¯õ]zxU öPõskÒÍ uØöPõø»UPõÚ Põµn[PÒ  
0 `Ç|ø»ø¯z uÚUS \õuP©õP öPõÒÁuõÀ ©ØÓÁºPÎß PÁÚzøuz 
uß £UP® v¸¨¤ £È Áõ[SÁx.  
 1 0–2 BQ¯ Cµsiß ÷\ºUøP 
 2 ¤µa\øÚPÎ¼¸¢x u¨¦ÁxAÀ»x ¤µa\øÚPøÍz wº¨£x.  
 
III. Characteristics of Contemplated Attempt 
12. uØöPø» ö\´x öPõÒÐ® ¬øÓ  
 (SÔ¨¤mh ¬øÓ vmh® wmkuÀ) 
 0 Aøu¨ £ØÔ ÷¯õ]UPÂÀø» 
1 Aøu¨ £ØÔ ÷¯õ\øÚ ö\´v¸UQÓõº   BÚõÀ Â£µ©õÚ 
vmh® CÀø» 
2 ]Ö Âå¯[PøÍ PÁÚzvÀ öPõsk {ßÓõPz vmh® u¯õ¶zv¸¨£x.  
 
 
13. Method - availability / Opportunity 
 ÷uº¢öukzv¸US® ¬øÓ°ß Qmk® ußø© \¢uº¨£®) 
0 ÷uº¢öukzv¸US® ¬øÓ QøhUP Áõ´¨¤Àø». \¢uº¨£®  CÀø».  
1. C¢u ¬øÓUS |øÓ¯ ÷{µ¬® ¬¯Ø]²® ÷uøÁ. C¢u ¬øÓø¯ Aøh¯ 
\¢uº¨£® AvP® CÀø».  
2(a)   C¢u ¬øÓ²® Aøu ö\´x öPõÒÍUTi¯ \¢uº¨£¬® QøhUS®. 
2(b)  GvºPõ»zvÀ C¢u ¬øÓ²®, Aøu ö\´¯ \¢uº¨£¬® Qmk® GßÓ 
Gvº£õº¨¦ 
 
14. C¢u Põ¶¯zøu GÆÁÍÄ yµ® ö\´x öPõÒÍ¬i²® Gß£øu¨ £ØÔ¯ P¸zx. 
0. øu¶¯® C»ø». EÖv CÀø», £¯® ö´x öPÒÐ® \õ©ºzv¯® 
CÀø».  
1. øu¶¯®, \õ©ºzv¯® BQ¯ÁØÓø¨ £ØÔ¯ öuÎÁÚ P¸zx CÀø».  
2. øu¶¯®, \õ©ºzv¯® BQ¯ÁØøÓ¨ £ØÔ EÖv¯õÚ ußÚ®¤UøP E 
ÒÍx.  
 
15. ¬¯Ø]ø¯U SÔzx C¸US® Gvº£õº¨¦ 
 0. GxÁ® CÀø» 
 1. \¶¯õPz öu¶¯ÂÀø».  
 2. C¸UQÓx.  
 
IV. ACTUALISATION OF CONTEMPLETED ATTEMPT  
(]¢uøÚø¯ ö\¯»õUSuÀ) 
16. HØ£õkPÒ 
 0. HxÄ® CÀø» 
1. KµÍÄUS EÒÍx (E®) ©õzvøµPøÍ ÷\ºzx øÁUP Bµ®£®  
2. ¬Êø©¯õP EÒÍx (E®)  ©õzvøµPÒ C¸UQßÓÚ.  SskPÒ  
÷£õmh x¨£õUQ BQ¯øÁ u¯õµõP C¸¨£x.  
 
 
17. uØöPõø»U Piu®  
 0. GxÄ® CÀø» 
1. GÊu Bµ®¤zuõ°ØÖ. BÚõÀ ¬iUPÂÀø». 
 2. Ax GÊ® Gsn® ©mk® C¸UQÓx.  
 
18. \õøÁ Gvº÷{õUQ ö\´v¸US®   CÖv HØ£õkPÒ  – (E®) Cß`µßì E°À  
£¶_PÒ  
 0. GxÄ® CÀø» 
 1. Aøu¨ £ØÔ Gso ]» HØ£õkPÒ ö\´v¸UQÓõº. 
2. Aøu¨ £ØÔ {ßS vmhªmk HØ£õkPøÍ ¬izv¸¨£x.  
 
19. B÷»õ\øÚ ö\´x öPõsi¸US® ¬¯Ø]ø¯¨ ¤Ó¶hª¸¢x ©øÓ¨£x H©õØÖÁx.  
 (Refers to Communication of Ideation to interviewing clinician) 
 0. Gsn[PÒ  öÁÎ¨£øh¯õPU TÖuÀ  
1. ¬Êø©¯õP öÁÎ°hõ©À  ©øÓ¨£x  
2. ö£õ´ ö\õÀ» ©øÓUP H©õØÓ ¬¯Ø]. 
 
APPENDIX 5 
MONTGOMERY-ÅSBERG DEPRESSION RATING SCALE (MADRS) 
1. Apparent sadness Representing despondency, gloom and despair (more 
than just ordinary transient low spirits), reflected in speech, facial expression, 
and posture. Rate by depth and inability to brighten up.  
0 = No sadness.  
2 = Looks dispirited but does brighten up without difficulty.  
4 = Appears sad and unhappy most of the time.  
6 = Looks miserable all the time. Extremely despondent  
2. Reported sadness Representing reports of depressed mood, regardless of 
whether it is reflected in appearance or not. Includes low spirits, despondency 
or the feeling of being beyond help and without hope.  
0 = Occasional sadness in keeping with the circumstances.  
2 = Sad or low but brightens up without difficulty.  
4 = Pervasive feelings of sadness or gloominess. The mood is still influenced 
by external circumstances.  
6 = Continuous or unvarying sadness, misery or despondency.  
3. Inner tension Representing feelings of ill-defined discomfort, edginess, 
inner turmoil, mental tension mounting to either panic, dread or anguish. Rate 
according to intensity, frequency, duration and the extent of reassurance 
called for.  
0 = Placid. Only fleeting inner tension.  
2 = Occasional feelings of edginess and ill-defined discomfort.  
4 = Continuous feelings of inner tension or intermittent panic which the 
patient can only master with some difficulty.  
6 = Unrelenting dread or anguish. Overwhelming panic.  
4. Reduced sleep Representing the experience of reduced duration or depth of 
sleep compared to the subject's own normal pattern when well.  
0 = Sleeps as normal.  
2 = Slight difficulty dropping off to sleep or slightly reduced, light or fitful 
sleep.  
4 = Moderate stiffness and resistance  
6 = Sleep reduced or broken by at least 2 hours.  
5. Reduced appetite Representing the feeling of a loss of appetite compared 
with when-well. Rate by loss of desire for food or the need to force oneself to 
eat.  
0 = Normal or increased appetite.  
2 = Slightly reduced appetite.  
4 = No appetite. Food is tasteless.  
6 = Needs persuasion to eat at all.  
6. Concentration difficulties Representing difficulties in collecting one's 
thoughts mounting to an incapacitating lack of concentration. Rate according 
to intensity, frequency, and degree of incapacity produced.  
0 = No difficulties in concentrating.  
2 = Occasional difficulties in collecting one's thoughts.  
4 = Difficulties in concentrating and sustaining thought which reduced ability 
to read or hold a conversation.  
6 = Unable to read or converse without great difficulty.  
7. Lassitude Representing difficulty in getting started or slowness in initiating 
and performing everyday activities.  
0 = Hardly any difficulty in getting started. No sluggishness.  
2 = Difficulties in starting activities.  
4 = Difficulties in starting simple routine activities which are carried out with 
effort.  
6 = Complete lassitude. Unable to do anything without help.  
8. Inability to feel Representing the subjective experience of reduced interest 
in the surroundings, or activities that normally give pleasure. The ability to 
react with adequate emotion to circumstances or people is reduced.  
0 = Normal interest in the surroundings and in other people.  
2 = Reduced ability to enjoy usual interests.  
4 = Loss of interest in the surroundings. Loss of feelings for friends and 
acquaintances.  
 6 = The experience of being emotionally paralysed, inability to feel anger, 
grief or pleasure and a complete or even painful failure to feel for close 
relatives and friends.  
9. Pessimistic thoughts Representing thoughts of guilt, inferiority, self-
reproach, sinfulness, remorse and ruin.  
0 = No pessimistic thoughts.  
2 = Fluctuating ideas of failure, self-reproach or self- depreciation.  
4 = Persistent self-accusations, or definite but still rational ideas of guilt or 
sin. Increasingly pessimistic about the future.  
6 = Delusions of ruin, remorse or irredeemable sin. Self- accusations which 
are absurd and unshakable.  
10. Suicidal thoughts Representing the feeling that life is not worth living, 
that a natural death would be welcome, suicidal thoughts, and preparations for 
suicide. Suicide attempts should not in themselves influence the rating.  
0 = Enjoys life or takes it as it comes.  
2 = Weary of life. Only fleeting suicidal thoughts.  
4 = Probably better off dead. Suicidal thoughts are common, and suicide is 
considered as a possible solution, but without specific plans or intenstion.  
6 = Explicit plans for suicide when there is an opportunity. Active 
preparations for suicide.  
 
 
 
